DK3483593T3 - Luminescent-oxygen-channeling-immunoassay ved anvendelse af tre antistoffer og fremgangsmåder til fremstilling og anvendelse deraf - Google Patents
Luminescent-oxygen-channeling-immunoassay ved anvendelse af tre antistoffer og fremgangsmåder til fremstilling og anvendelse deraf Download PDFInfo
- Publication number
- DK3483593T3 DK3483593T3 DK18199087.0T DK18199087T DK3483593T3 DK 3483593 T3 DK3483593 T3 DK 3483593T3 DK 18199087 T DK18199087 T DK 18199087T DK 3483593 T3 DK3483593 T3 DK 3483593T3
- Authority
- DK
- Denmark
- Prior art keywords
- immunoassay
- luminescent
- antibodies
- procedures
- manufacture
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461970596P | 2014-03-26 | 2014-03-26 | |
| EP15767906.9A EP3123151B1 (en) | 2014-03-26 | 2015-03-24 | Luminescent oxygen channeling immunoassay utilizing three antibodies and methods of production and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3483593T3 true DK3483593T3 (da) | 2021-07-19 |
Family
ID=54196294
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15767906.9T DK3123151T3 (da) | 2014-03-26 | 2015-03-24 | Luminescent-oxygen-channeling-immunoassay ved anvendelse af tre antistoffer og fremgangsmåder til fremstilling og anvendelse deraf |
| DK18199087.0T DK3483593T3 (da) | 2014-03-26 | 2015-03-24 | Luminescent-oxygen-channeling-immunoassay ved anvendelse af tre antistoffer og fremgangsmåder til fremstilling og anvendelse deraf |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15767906.9T DK3123151T3 (da) | 2014-03-26 | 2015-03-24 | Luminescent-oxygen-channeling-immunoassay ved anvendelse af tre antistoffer og fremgangsmåder til fremstilling og anvendelse deraf |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20170176419A1 (da) |
| EP (2) | EP3123151B1 (da) |
| JP (1) | JP6596440B2 (da) |
| CN (1) | CN106662532B (da) |
| AU (1) | AU2015236288A1 (da) |
| CA (1) | CA2942281C (da) |
| DK (2) | DK3123151T3 (da) |
| ES (2) | ES2713428T3 (da) |
| IL (1) | IL247630A0 (da) |
| MX (1) | MX2016011809A (da) |
| WO (1) | WO2015148479A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018107013A1 (en) * | 2016-12-09 | 2018-06-14 | Abbott Point Of Care Inc. | Dual range cardiac troponin immunoassay devices and methods using immunosensor and magnetic immunosensor |
| WO2018107016A1 (en) | 2016-12-09 | 2018-06-14 | Abbott Point Of Care Inc. | Ameliorated crosstalk immunoassay test device for determining a concentration of an analyte |
| CA3046012A1 (en) | 2016-12-09 | 2018-06-14 | Abbott Point Of Care Inc. | Combined immunoassay and magnetic immunoassay systems and devices for extended range of sensitivity |
| EP3552019B1 (en) | 2016-12-09 | 2020-12-02 | Abbott Point of Care Inc. | Combined immunoassay and magnetic immunoassay methods for extended range of sensitivity |
| EP3552016A1 (en) | 2016-12-09 | 2019-10-16 | Abbott Point of Care Inc. | Extended range immunoassay devices with immunosensor and magnetic immunosensor |
| WO2018107012A1 (en) | 2016-12-09 | 2018-06-14 | Abbott Point Of Care Inc. | Crossover analytical systems and methods using an immunosensor and magnetic immunosensor |
| CN111770935A (zh) * | 2018-02-27 | 2020-10-13 | 株式会社岛津制作所 | 特异性识别APP669-x的N末端的抗体及免疫测定法 |
| WO2019167128A1 (ja) * | 2018-02-27 | 2019-09-06 | 株式会社 島津製作所 | サンドイッチ型免疫測定法 |
| EP3830556A4 (en) * | 2018-07-30 | 2021-09-01 | Siemens Healthcare Diagnostics Inc. | KITS, MICROFLUIDIC DEVICES AND METHODS FOR PERFORMING BIOTIN DOSES |
| EP3856927B1 (en) * | 2018-09-25 | 2023-01-11 | Siemens Healthcare Diagnostics Inc. | Compositions, kits, and methods for multiplex assays to correct for biotin interference in target analyte measurements |
| EP4022289A4 (en) * | 2019-08-29 | 2022-11-16 | Siemens Healthcare Diagnostics, Inc. | DEVICE AND METHOD FOR EVALUATING A FLUID SAMPLE ON A SINGLE USE MULTIPLE ANALYTICAL CONSUMABLE |
| CN111781385B (zh) * | 2020-08-19 | 2023-07-18 | 武汉生之源生物科技股份有限公司 | 一种NT-proBNP检测试剂盒及其制备方法 |
| CN114544978A (zh) * | 2022-03-04 | 2022-05-27 | 美康生物科技股份有限公司 | 一种igf-1检测试剂盒及其制备方法和检测方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| NO164622C (no) * | 1988-05-11 | 1990-10-24 | Tore Lindmo | Binaer immunometrisk partikkelbasert metode for maaling av spesifikke serum-antigener ved hjelp av vaeskestroemsmikrofotometri og et ferdigpreparert maaloppsett derav. |
| CA2090126C (en) | 1990-08-02 | 2002-10-22 | John W. Schrader | Methods for the production of proteins with a desired function |
| US5340716A (en) | 1991-06-20 | 1994-08-23 | Snytex (U.S.A.) Inc. | Assay method utilizing photoactivated chemiluminescent label |
| US6251581B1 (en) * | 1991-05-22 | 2001-06-26 | Dade Behring Marburg Gmbh | Assay method utilizing induced luminescence |
| ATE208039T1 (de) * | 1991-05-22 | 2001-11-15 | Dade Behring Marburg Gmbh | Bestimmungsmethoden unter verwendung von induzierter lumineszenz |
| US7285418B2 (en) * | 1996-06-25 | 2007-10-23 | Hytest Ltd. | Method and kit for the diagnosis of troponin I |
| US6248546B1 (en) * | 1998-03-09 | 2001-06-19 | Diagnostic Systems Laboratories, Inc. | Assay of IGFBP complex |
| US6703248B1 (en) * | 1999-12-15 | 2004-03-09 | Dade Behring Marburg Gmbh | Particles for diagnostic and therapeutic use |
| DE10064827A1 (de) * | 2000-12-22 | 2002-06-27 | Dade Behring Marburg Gmbh | Nachweisverfahren |
| US6551788B1 (en) * | 2001-11-28 | 2003-04-22 | Beckman Coulter, Inc. | Particle-based ligand assay with extended dynamic range |
| US6764819B2 (en) * | 2002-07-16 | 2004-07-20 | Emp Biotech Gmbh | Method for chemiluminescent detection |
| DE112004001863T5 (de) * | 2003-10-03 | 2006-09-07 | Scantibodies Laboratory, Inc., Santee | Verfahren und Verwendung von Bindungskomponenten zur Verbesserung der Testspezifität |
| US20090087859A1 (en) * | 2004-09-20 | 2009-04-02 | Johnson Brandon T | Microfluidic device for detecting soluble molecules |
| WO2006119203A2 (en) * | 2005-04-29 | 2006-11-09 | Beckman Coulter | Fluorescence lateral flow immunoassay |
| GB2436616A (en) * | 2006-03-29 | 2007-10-03 | Inverness Medical Switzerland | Assay device and method |
| CN104198705B (zh) * | 2006-09-21 | 2017-06-09 | 雀巢产品技术援助有限公司 | 检测稀有循环细胞内多种信号转导分子的基于抗体的阵列 |
| WO2008104183A2 (en) * | 2007-03-01 | 2008-09-04 | Symphogen A/S | Recombinant anti-epidermal growth factor receptor antibody compositions |
| US7790401B2 (en) * | 2007-08-06 | 2010-09-07 | Siemens Healthcare Diagnostics | Methods for detection of immunosuppressant drugs |
| US20090170218A1 (en) * | 2008-01-02 | 2009-07-02 | Dade Behring Inc. | Methods for detection of cyclosporin a |
| US20120288961A1 (en) * | 2009-12-22 | 2012-11-15 | University Of Washington | Capillarity-based devices for performing chemical processes and associated systems and methods |
| US9678068B2 (en) * | 2010-03-01 | 2017-06-13 | Quanterix Corporation | Ultra-sensitive detection of molecules using dual detection methods |
| US10088490B2 (en) * | 2010-08-20 | 2018-10-02 | Siemens Healthcare Diagnostics Inc. | Assay for analytes using multiple receptors |
| CN102565381B (zh) * | 2010-12-08 | 2014-06-18 | 中国科学院生态环境研究中心 | 导电微粒子介导电化学发光信号的免疫检测方法 |
| DK2760998T3 (da) | 2011-11-22 | 2017-04-24 | Siemens Healthcare Diagnostics Inc | Indretninger med tørrede reagenser til rekonstitution som kalibrerings- og/eller kvalitetskontrolløsninger, og fremgangsmåder til fremstilling og anvendelse deraf |
| DK3418743T3 (da) * | 2013-03-15 | 2020-08-03 | Siemens Healthcare Diagnostics Inc | Luminescent oxygenkanaliseringsimmunoassays til brug ved elektrokemisk afladning af singlet oxygen og fremgangsmåde til fremstilling og anvendelse deraf |
| US20160320415A1 (en) * | 2013-12-16 | 2016-11-03 | Xen Biofluidx, Inc. | Fast reconstituting reagent pellets |
-
2015
- 2015-03-24 EP EP15767906.9A patent/EP3123151B1/en active Active
- 2015-03-24 CN CN201580024761.3A patent/CN106662532B/zh active Active
- 2015-03-24 MX MX2016011809A patent/MX2016011809A/es active IP Right Grant
- 2015-03-24 ES ES15767906T patent/ES2713428T3/es active Active
- 2015-03-24 DK DK15767906.9T patent/DK3123151T3/da active
- 2015-03-24 DK DK18199087.0T patent/DK3483593T3/da active
- 2015-03-24 US US15/128,479 patent/US20170176419A1/en not_active Abandoned
- 2015-03-24 AU AU2015236288A patent/AU2015236288A1/en not_active Abandoned
- 2015-03-24 EP EP18199087.0A patent/EP3483593B1/en active Active
- 2015-03-24 WO PCT/US2015/022209 patent/WO2015148479A1/en active Application Filing
- 2015-03-24 JP JP2016557105A patent/JP6596440B2/ja active Active
- 2015-03-24 ES ES18199087T patent/ES2884930T3/es active Active
- 2015-03-24 CA CA2942281A patent/CA2942281C/en active Active
-
2016
- 2016-09-05 IL IL247630A patent/IL247630A0/en unknown
-
2021
- 2021-01-22 US US17/155,642 patent/US20210231647A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210231647A1 (en) | 2021-07-29 |
| EP3123151B1 (en) | 2018-11-28 |
| IL247630A0 (en) | 2016-11-30 |
| CN106662532B (zh) | 2019-12-13 |
| EP3483593A1 (en) | 2019-05-15 |
| MX2016011809A (es) | 2017-05-10 |
| AU2015236288A1 (en) | 2016-09-15 |
| WO2015148479A1 (en) | 2015-10-01 |
| EP3483593B1 (en) | 2021-04-28 |
| CA2942281A1 (en) | 2015-10-01 |
| JP6596440B2 (ja) | 2019-10-23 |
| ES2713428T3 (es) | 2019-05-21 |
| EP3123151A1 (en) | 2017-02-01 |
| US20170176419A1 (en) | 2017-06-22 |
| CN106662532A (zh) | 2017-05-10 |
| JP2017508971A (ja) | 2017-03-30 |
| CA2942281C (en) | 2023-03-14 |
| DK3123151T3 (da) | 2019-03-18 |
| ES2884930T3 (es) | 2021-12-13 |
| EP3123151A4 (en) | 2017-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3193929T3 (da) | Behandlingsregimer ved anvendelse af anti-nkg2a-antistoffer | |
| DK3280441T3 (da) | Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3227336T3 (da) | Anti-CD79b-antistoffer og fremgangsmåder til anvendelse | |
| DK3258951T3 (da) | Anti-pvrig antistoffer og fremgangsmåder for anvendelse | |
| DK3221359T3 (da) | Fremgangsmåder til tumorbehandling ved anvendelse af CD3XCD20-bispecifikt antistof | |
| DK3483593T3 (da) | Luminescent-oxygen-channeling-immunoassay ved anvendelse af tre antistoffer og fremgangsmåder til fremstilling og anvendelse deraf | |
| DK3303394T3 (da) | Anti-ctla-4-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3186376T3 (da) | Fremgangsmåder til forbedring af cas9-medieret manipulationseffektivitet | |
| DK3556775T3 (da) | Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter | |
| DK3110988T3 (da) | Metoder til behandling af lithiumholdige materialer | |
| DK3229838T3 (da) | Anti-C10orf54-antistoffer og anvendelser deraf | |
| DK3215532T3 (da) | Anti-TIM3-antistoffer og fremgangsmåder til anvendelse | |
| DK3126388T3 (da) | Anti-EGFRvIII-antistoffer og anvendelser deraf | |
| DK3215147T3 (da) | Neurodæmpende norketamin-forbindelser og fremgangsmåder | |
| DK3286311T3 (da) | Fremgangsmåde til behandling af maligniteter | |
| DK3137605T3 (da) | Sammensætninger og fremgangsmåder til modulering af angiopoietin-lignende-3-ekspression | |
| DK3294700T3 (da) | Fremgangsmåde til fremstilling af limonen-4-ol | |
| DK3116911T3 (da) | Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse | |
| DK3134130T3 (da) | Sammensætninger og fremgangsmåder til behandling af hæmoglobinopatier | |
| DK3172233T3 (da) | Anti-cd74-antistoffer, sammensætninger omfattende anti-cd74- antistoffer og fremgangsmåder til anvendelse af anti-cd74-antistoffer | |
| DK3113797T3 (da) | Antistoffer, anvendelser og fremgangsmåder | |
| DK3127923T3 (da) | Fremgangsmåde til forbedring af oppløselighed af protein og peptid ved hjælp af immunoglobulin-fc-fragment-binding | |
| DK3083680T3 (da) | Humaniserede anti-Tau(pS422)-antistoffer og fremgangsmåder til anvendelse | |
| DK3200815T3 (da) | Fremgangsmåder og sammensætninger til behandling af cancer | |
| DK2924093T3 (da) | Multicarboxylat-sammensætninger og fremgangsmåde til fremstilling af disse |